2Roy SN,Bhattaeharya S.Benefits and risks of pharmacological a- gents used for the treatment of menorthagia [J].Drug Safe,2004,27 (2):75-90.
3Xiao BL Wh SC,Chong J,et al.Therapeutic effects of the lenonorgestrel relesing intrauterina system in the treatment of idio- pathic menorrhagia[J].Fertil Steril,2003,79(4):963-969.
4Barrington JW,Arunkalaivanan AS,Abdel-Fattah M.Comparison between the levonorgestrel intrauterine system (LNG-IUS)and ther- mal balloon ablation in the treatment of menorrhagia [J].Eur J Obstet Gyneeol Reprod Biol, 2003,108:72-74.
5Hurskainen R, Teperi J, Rissanen P, et al. Levonorgestrel-releas- ing intrauterine system in the treatment of heavy menstrual bleeding [J]. Curt Opin Obstet Gyneeol,2004,16:487-490.
6Lockh at FB, Em em bolu JO, Konje JC. The efficacy, side ef- fects and continuation rates in women with symptomatic endom etrios is under going treatment with an intrauterineadm in is tered progestogen(Levonorgestrel): A 3 year followup [J] . Obstet Gynecol Surv, 2005,60(7 ):443-445.
7Horn LC, Schanrrbuseh U, Bilek K, et al. Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologie analysis in eases with and without progestogen treatment [ J ]. Int J Gynecol Cancer, 2004, 14:348 - 353.
8Varila E, Wahlstrom T, Rauramo I. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy [ J ]. Fertil Steril, 2001, 76 ( 5 ) : 969 - 973.
9Zalel Y, Shulman A, Lidor A, et al. The local progestational effect of the levonorgestrel-releasing intrauterine system: A sonographie and Doppler flow study [ J ]. Hum Reprod, 2002, 17 ( 11 ) : 2878 - 2880.
10[2]Baruah S, Etherington IJ. Short-term and long-term outcome of management of menorrhagia with a balloon thermo-ablation system[J]. J Obstet Gynaecol. 2003 Jul;23(4)∶431-2.
